{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32956650",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "09",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jid.2020.09.002",
      "S0022-202X(20)32068-6"
    ],
    "Journal": {
      "ISSN": "1523-1747",
      "JournalIssue": {
        "Volume": "141",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "The Journal of investigative dermatology",
      "ISOAbbreviation": "J Invest Dermatol"
    },
    "ArticleTitle": "Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms.",
    "Pagination": {
      "StartPage": "727",
      "EndPage": "731",
      "MedlinePgn": "727-731"
    },
    "Abstract": {
      "AbstractText": [
        "This Perspective briefly reviews the relationship between UV-induced mutations in habitually sun-exposed human skin and subsequent development of actinic keratoses (AKs) and skin cancers. It argues that field therapy rather than AK-selective therapy is the more logical approach to cancer prevention and hypothesizes that treatment early in the process of field cancerization, even prior to the appearance of AKs, may be more effective in preventing cancer as well as more beneficial for and better tolerated by at-risk individuals. Finally, the Perspective encourages use of rapidly advancing DNA analysis techniques to quantify mutational burden in sun-damaged skin and its reduction by various therapies."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 The Author. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: bgilchrest@mgh.harvard.edu."
          }
        ],
        "LastName": "Gilchrest",
        "ForeName": "Barbara A",
        "Initials": "BA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Invest Dermatol",
    "NlmUniqueID": "0426720",
    "ISSNLinking": "0022-202X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Sunscreening Agents"
    },
    {
      "RegistryNumber": "U3P01618RT",
      "NameOfSubstance": "Fluorouracil"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Cutaneous"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology",
        "prevention & control"
      ],
      "DescriptorName": "Carcinoma, Basal Cell"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology",
        "prevention & control"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology",
        "radiation effects"
      ],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Chemexfoliation"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Cryosurgery"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Curettage"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "DNA Damage"
    },
    {
      "QualifierName": [],
      "DescriptorName": "DNA Mutational Analysis"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Dermatology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Electrocoagulation"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Fluorouracil"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathology",
        "radiation effects"
      ],
      "DescriptorName": "Keratinocytes"
    },
    {
      "QualifierName": [
        "etiology",
        "genetics",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Keratosis, Actinic"
    },
    {
      "QualifierName": [
        "radiation effects"
      ],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Photochemotherapy"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathology",
        "radiation effects"
      ],
      "DescriptorName": "Skin"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology",
        "prevention & control"
      ],
      "DescriptorName": "Skin Neoplasms"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Sunscreening Agents"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Ultraviolet Rays"
    }
  ]
}